newsfilter
← Latest News
GlobeNewswire·

Codiak BioSciences to Participate 5th Annual Evercore ISI HealthCONx Conference

CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (NASDAQ:CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of